TrialClinical drug investigation2025

Safety, Tolerability, and Pharmacokinetics of a Novel Anti-obesity Agent, S-309309, in Healthy Adults with or Without Obesity.

Toru Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.